VERTEPORFIN FOR INJECTION

VERTEPORFIN FOR INJECTION was reported 1481 times

VERTEPORFIN FOR INJECTION is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 POLYPOIDAL CHOROIDAL VASCULOPATHY 134 0.4323
1 CHOROIDAL HAEMATOMA 3 0.2727
2 CHOROIDAL HAEMANGIOMA 2 0.2500
3 ANTERIOR CHAMBER COLLAPSE 1 0.2000
4 BENIGN NEOPLASM OF CHOROID 1 0.1429
5 CHOROIDAL DYSTROPHY 6 0.1250
6 SUBRETINAL FIBROSIS 24 0.1231
7 CHOROIDAL NEOVASCULARISATION 99 0.1154
8 CHORIORETINAL DISORDER 22 0.1117
9 CHOROIDAL INFARCTION 13 0.1083
10 RETINAL PIGMENT EPITHELIAL TEAR 74 0.1066
11 EXUDATIVE RETINOPATHY 6 0.1053
12 CHOROIDAL RUPTURE 2 0.1053
13 HAEMANGIOMA OF RETINA 1 0.1000
14 SUBRETINAL HAEMATOMA 4 0.0889
15 MACULAR SCAR 15 0.0773
16 MACULAR PSEUDOHOLE 2 0.0769
17 ANGIOGRAM ABNORMAL 8 0.0714
18 CHORIORETINAL ATROPHY 14 0.0676
19 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 58 0.0652
20 VITREOUS INJURY 2 0.0625
21 CHOROIDAL HAEMORRHAGE 12 0.0622
22 AGE-RELATED MACULAR DEGENERATION 87 0.0573
23 RETINAL DEPIGMENTATION 15 0.0490
24 CHORIORETINAL SCAR 4 0.0482
25 EYE LASER SCAR 1 0.0455
26 RETINAL PIGMENT EPITHELIOPATHY 18 0.0417
27 LOCALISED EXFOLIATION 1 0.0417
28 RETINAL SCAR 19 0.0412
29 CONJUNCTIVAL DEFECT 1 0.0385
30 INFUSION SITE BURNING 1 0.0370
31 RETINAL PIGMENT EPITHELIUM CHANGE 1 0.0345
32 PATHOLOGIC MYOPIA 1 0.0333
33 ANGIOGRAM RETINA ABNORMAL 1 0.0333
34 RETINAL INFILTRATES 2 0.0328
35 VITREOUS LOSS 2 0.0323
36 SUBRETINAL FLUID 33 0.0302
37 RETINAL HAEMORRHAGE 212 0.0297
38 ADRENOCORTICAL INSUFFICIENCY CHRONIC 1 0.0263
39 CEREBRAL ATHEROSCLEROSIS 1 0.0256
40 INFUSION SITE EROSION 1 0.0244
41 RETINAL CYST 4 0.0241
42 HAEMOGLOBIN URINE 1 0.0233
43 VITREOUS HAEMORRHAGE 63 0.0228
44 RETINAL OEDEMA 41 0.0214
45 RETINAL ISCHAEMIA 13 0.0213
46 HAEMANGIOBLASTOMA 1 0.0208
47 RETINAL EXUDATES 19 0.0203
48 PSEUDOENDOPHTHALMITIS 2 0.0202
49 RETINAL NEOVASCULARISATION 5 0.0198
50 RETINAL DEGENERATION 25 0.0192
51 SCOTOMA 14 0.0189
52 EYE OPERATION COMPLICATION 3 0.0183
53 TACHYPHYLAXIS 6 0.0172
54 FLAT ANTERIOR CHAMBER OF EYE 3 0.0168
55 MACULAR HOLE 22 0.0164
56 MEDIAN NERVE INJURY 1 0.0161
57 RETINOPATHY PROLIFERATIVE 3 0.0154
58 CORNEAL DEFECT 2 0.0152
59 CORNEAL THICKENING 1 0.0147
60 TOXOPLASMA SEROLOGY POSITIVE 1 0.0147
61 METAMORPHOPSIA 27 0.0146
62 RETINOSCHISIS 2 0.0145
63 PROCALCITONIN DECREASED 1 0.0143
64 RETINAL VASCULAR DISORDER 8 0.0137
65 CHOROIDITIS 5 0.0134
66 CYSTOID MACULAR OEDEMA 25 0.0133
67 RETINAL DYSTROPHY 3 0.0126
68 VISUAL ACUITY REDUCED 399 0.0120
69 VAGINAL OPERATION 1 0.0119
70 MACULAR CYST 1 0.0119
71 CAMPYLOBACTER COLITIS 1 0.0116
72 OPHTHALMOLOGICAL EXAMINATION ABNORMAL 2 0.0113
73 NERVE DEGENERATION 2 0.0111
74 INFUSION SITE HYPOAESTHESIA 1 0.0105
75 INFUSION SITE NECROSIS 2 0.0104
76 INFUSION SITE PARAESTHESIA 1 0.0099
77 OCULAR VASCULAR DISORDER 8 0.0097
78 SEROUS RETINAL DETACHMENT 8 0.0095
79 OPTIC DISC DISORDER 2 0.0095
80 RETINOBLASTOMA 1 0.0092
81 RETINAL DISORDER 23 0.0088
82 VITREOUS ADHESIONS 1 0.0087
83 ANTERIOR CHAMBER FLARE 2 0.0086
84 SYNCOPE VASOVAGAL 7 0.0085
85 RETINITIS VIRAL 1 0.0083
86 MACULAR DETACHMENT 2 0.0083
87 HEPATITIS C POSITIVE 1 0.0082
88 KERATITIS HERPETIC 1 0.0082
89 RETINAL INFARCTION 2 0.0081
90 IRIS NEOVASCULARISATION 1 0.0080
91 CONJUNCTIVAL DISORDER 3 0.0079
92 OPTIC NERVE CUPPING 1 0.0079
93 PHLEBOTHROMBOSIS 1 0.0078
94 CHLOROPSIA 1 0.0078
95 ATROPHY OF GLOBE 1 0.0078
96 BACTERIA BLOOD IDENTIFIED 1 0.0076
97 LEUKOSTASIS SYNDROME 1 0.0075
98 REPERFUSION INJURY 1 0.0072
99 RETINAL DETACHMENT 66 0.0072
100 LEUKAEMIC INFILTRATION 1 0.0071
101 BEHCET'S SYNDROME 1 0.0070
102 NECROTISING SCLERITIS 1 0.0069
103 CORNEAL EPITHELIUM DEFECT 4 0.0069
104 MACULAR OEDEMA 38 0.0068
105 VISUAL ACUITY REDUCED TRANSIENTLY 2 0.0065
106 VITREOUS DISORDER 3 0.0062
107 HLA MARKER STUDY POSITIVE 1 0.0061
108 RETINAL DRUSEN 1 0.0061
109 VITREOUS DEGENERATION 1 0.0061
110 FOETAL MALPOSITION 1 0.0060
111 MACULAR FIBROSIS 4 0.0059
112 HYPHAEMA 3 0.0057
113 INSTILLATION SITE SWELLING 1 0.0057
114 RETINAL VASCULAR THROMBOSIS 3 0.0057
115 BLOOD GLUCOSE 1 0.0056
116 PANOPHTHALMITIS 1 0.0055
117 DRY AGE-RELATED MACULAR DEGENERATION 6 0.0054
118 PSYCHOSOMATIC DISEASE 1 0.0053
119 NIPPLE EXUDATE BLOODY 1 0.0053
120 PROCEDURAL HYPERTENSION 1 0.0053
121 SMOOTH MUSCLE ANTIBODY POSITIVE 1 0.0053
122 CAPILLARY DISORDER 2 0.0052
123 OCULAR PROCEDURAL COMPLICATION 1 0.0052
124 MACULOPATHY 18 0.0051
125 EYE INFECTION TOXOPLASMAL 2 0.0050
126 ALCOHOLIC 1 0.0050
127 RETINAL DEPOSITS 1 0.0049
128 CATARACT SUBCAPSULAR 3 0.0049
129 CHORIORETINOPATHY 7 0.0049
130 EYE EXCISION 1 0.0049
131 MACULAR DEGENERATION 58 0.0049
132 RHEGMATOGENOUS RETINAL DETACHMENT 1 0.0048
133 MELANOMA RECURRENT 2 0.0048
134 BACTERIA URINE IDENTIFIED 1 0.0047
135 VITREOUS OPACITIES 4 0.0047
136 COMPLICATIONS OF TRANSPLANTED HEART 1 0.0047
137 FIBROSIS 14 0.0045
138 RETINAL TEAR 11 0.0045
139 SENSORY LEVEL ABNORMAL 1 0.0044
140 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 6 0.0043
141 RETINAL VASCULAR OCCLUSION 3 0.0041
142 CORNEAL SCAR 2 0.0040
143 SKIN DESQUAMATION 1 0.0040
144 URTICARIA PAPULAR 1 0.0039
145 RETINAL INJURY 3 0.0039
146 HYPERHOMOCYSTEINAEMIA 1 0.0038
147 INSTILLATION SITE DISCHARGE 1 0.0038
148 EPIRETINAL MEMBRANE 1 0.0036
149 SALIVARY GLAND NEOPLASM 1 0.0035
150 VITRECTOMY 2 0.0034
151 FEMORAL ARTERY OCCLUSION 1 0.0032
152 RUPTURED CEREBRAL ANEURYSM 2 0.0031
153 INJECTION SITE ANAESTHESIA 1 0.0031
154 ATROPHY 6 0.0031
155 ADMINISTRATION SITE SWELLING 1 0.0031
156 CATARACT NUCLEAR 2 0.0030
157 PNEUMONIA ESCHERICHIA 1 0.0029
158 POSTERIOR CAPSULE OPACIFICATION 1 0.0029
159 CHRONIC OBSTRUCTIVE AIRWAYS DISEASE EXACERBATED 1 0.0029
160 RETINAL VEIN THROMBOSIS 2 0.0029
161 ANION GAP DECREASED 1 0.0029
162 HYPOPERFUSION 3 0.0029
163 HAEMORRHAGIC CEREBRAL INFARCTION 2 0.0028
164 BURNS SECOND DEGREE 5 0.0028
165 FAECAL OCCULT BLOOD POSITIVE 1 0.0028
166 VITREOUS DETACHMENT 6 0.0028
167 GASTROINTESTINAL TRACT ADENOMA 1 0.0027
168 CHROMATOPSIA 2 0.0026
169 ALBUMIN URINE PRESENT 1 0.0026
170 ALKALOSIS 1 0.0026
171 VEIN COLLAPSE 2 0.0026
172 ADMINISTRATION SITE REACTION 1 0.0026
173 CONGENITAL DIAPHRAGMATIC HERNIA 1 0.0026
174 CHOROIDAL EFFUSION 2 0.0025
175 INJECTION SITE NECROSIS 5 0.0025
176 ANTEPARTUM HAEMORRHAGE 1 0.0024
177 INFUSION SITE OEDEMA 2 0.0024
178 PERICARDITIS CONSTRICTIVE 1 0.0024
179 CEREBELLAR INFARCTION 4 0.0024
180 GLIOSIS 1 0.0023
181 NECROSIS ISCHAEMIC 1 0.0022
182 LOCKED-IN SYNDROME 1 0.0022
183 RETINAL VEIN OCCLUSION 6 0.0021
184 ENCEPHALITIS HERPES 1 0.0020
185 HYPERCREATININAEMIA 1 0.0020
186 URINARY TRACT PAIN 1 0.0020
187 PULSE PRESSURE DECREASED 1 0.0020
188 EXTRAVASATION 8 0.0019
189 KELOID SCAR 1 0.0019
190 INTRAOCULAR PRESSURE DECREASED 1 0.0019
191 EYE HAEMORRHAGE 25 0.0019
192 CORNEAL EROSION 1 0.0019
193 HAEMORRHAGIC DISORDER 2 0.0018
194 CHOROIDAL DETACHMENT 1 0.0018
195 VISUAL FIELD DEFECT 13 0.0018
196 RETINAL THICKENING 3 0.0018
197 BRAIN SCAN ABNORMAL 1 0.0018
198 VISUAL DISTURBANCE 10 0.0017
199 EYE BURNS 1 0.0017
200 ANTERIOR CHAMBER INFLAMMATION 1 0.0017
201 CONTRAST MEDIA ALLERGY 3 0.0016
202 OPEN ANGLE GLAUCOMA 1 0.0016
203 PROSTATE CANCER RECURRENT 1 0.0016
204 RETINAL ARTERY OCCLUSION 4 0.0016
205 ANGLE CLOSURE GLAUCOMA 4 0.0016
206 NECROTISING RETINITIS 1 0.0016
207 ANOXIC ENCEPHALOPATHY 1 0.0016
208 IATROGENIC INJURY 2 0.0016
209 DACRYOSTENOSIS ACQUIRED 2 0.0015
210 CONCOMITANT DISEASE PROGRESSION 3 0.0015
211 EXTRADURAL HAEMATOMA 2 0.0015
212 POST PROCEDURAL DISCHARGE 1 0.0015
213 NEOPLASM RECURRENCE 5 0.0015
214 NO ADVERSE DRUG EFFECT 1 0.0015
215 DISEASE PROGRESSION 173 0.0015
216 INFUSION SITE RASH 2 0.0015
217 URINE LEUKOCYTE ESTERASE POSITIVE 1 0.0014
218 PERINEAL PAIN 1 0.0014
219 LEGAL PROBLEM 1 0.0014
220 CORNEAL OEDEMA 3 0.0013
221 CARBOHYDRATE ANTIGEN 15-3 INCREASED 1 0.0013
222 MYASTHENIC SYNDROME 1 0.0013
223 VASCULAR RUPTURE 2 0.0013
224 ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY 1 0.0013
225 INJECTION SITE BURNING 1 0.0013
226 CORNEAL TRANSPLANT 1 0.0013
227 RETINAL PIGMENTATION 1 0.0013
228 INTRAOCULAR PRESSURE INCREASED 16 0.0013
229 LYMPHOCYTE STIMULATION TEST POSITIVE 1 0.0012
230 HEAT EXHAUSTION 1 0.0012
231 VEIN RUPTURE 2 0.0012
232 NON-INFECTIOUS ENDOPHTHALMITIS 1 0.0012
233 INJECTION SITE OEDEMA 2 0.0012
234 GASTROINTESTINAL NEOPLASM 1 0.0012
235 PUPIL FIXED 2 0.0012
236 THALAMUS HAEMORRHAGE 1 0.0011
237 INJECTION SITE EXTRAVASATION 14 0.0011
238 ANGIONEUROTIC OEDEMA 3 0.0011
239 INFUSION SITE EXTRAVASATION 7 0.0011
240 CONJUNCTIVAL HYPERAEMIA 4 0.0011
241 EXTENSOR PLANTAR RESPONSE 1 0.0011
242 PUPILLARY REFLEX IMPAIRED 2 0.0011
243 SKIN GRAFT 1 0.0011
244 MENINGIOMA BENIGN 1 0.0011
245 VENOUS INJURY 1 0.0011
246 RAYNAUD'S PHENOMENON 1 0.0011
247 BLOOD IRON ABNORMAL 1 0.0010
248 SHOULDER PAIN 1 0.0010
249 OROPHARYNGEAL SWELLING 1 0.0010
250 HEMIANOPIA 1 0.0010
251 DRUG EXPOSURE BEFORE PREGNANCY 1 0.0010
252 BURNS THIRD DEGREE 1 0.0009
253 HEPATIC NEOPLASM MALIGNANT 2 0.0009
254 ASTERIXIS 1 0.0009
255 BLINDNESS UNILATERAL 13 0.0009
256 PROCEDURAL COMPLICATION 7 0.0009
257 COMPLEX PARTIAL SEIZURES 1 0.0009
258 CATHETER RELATED COMPLICATION 1 0.0009
259 HALO VISION 1 0.0009
260 READING DISORDER 2 0.0009
261 INFECTION REACTIVATION 1 0.0009
262 PERIPHERAL EMBOLISM 1 0.0009
263 ADMINISTRATION SITE PAIN 1 0.0009
264 LUMBAR RADICULOPATHY 1 0.0009
265 GLOMERULONEPHRITIS MEMBRANOUS 1 0.0009
266 MYOPIA 2 0.0008
267 RECTAL PROLAPSE 1 0.0008
268 CLOSTRIDIUM COLITIS 1 0.0008
269 CEREBRAL INFARCTION 20 0.0008
270 EYE OEDEMA 2 0.0008
271 BLINDNESS 33 0.0008
272 PALATAL OEDEMA 1 0.0008
273 VASODILATATION 2 0.0008
274 PHOTOPSIA 5 0.0008
275 CAROTID ARTERY DISEASE 1 0.0008
276 NOCTURNAL DYSPNOEA 1 0.0008
277 LEFT ATRIAL DILATATION 1 0.0008
278 CYSTITIS NONINFECTIVE 1 0.0007
279 CORNEAL OPACITY 1 0.0007
280 CORNEAL ABRASION 1 0.0007
281 ANAPHYLACTOID REACTION 3 0.0007
282 BILIARY TRACT DISORDER 1 0.0007
283 THERAPEUTIC PROCEDURE 1 0.0007
284 INFUSION SITE ERYTHEMA 6 0.0007
285 TONIC CONVULSION 1 0.0007
286 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 1 0.0007
287 ACUTE ABDOMEN 1 0.0007
288 INFUSION SITE INDURATION 1 0.0007
289 PITUITARY TUMOUR 1 0.0007
290 SUNBURN 5 0.0007
291 INFUSION SITE REACTION 2 0.0007
292 ASTIGMATISM 1 0.0007
293 INJECTION SITE PARAESTHESIA 1 0.0007
294 MEAN CELL VOLUME DECREASED 1 0.0006
295 NEURITIS 1 0.0006
296 HYPERTROPHIC CARDIOMYOPATHY 1 0.0006
297 IRIDOCYCLITIS 2 0.0006
298 METABOLIC ALKALOSIS 1 0.0006
299 AORTIC VALVE DISEASE 1 0.0006
300 SKULL FRACTURE 1 0.0006
301 ANGINA UNSTABLE 4 0.0006
302 INJECTION SITE INFECTION 2 0.0006
303 SKIN INJURY 2 0.0006
304 CYTOLYTIC HEPATITIS 2 0.0006
305 ENTERITIS INFECTIOUS 1 0.0006
306 SKIN NECROSIS 3 0.0006
307 PAPILLARY THYROID CANCER 1 0.0006
308 VERTIGO POSITIONAL 1 0.0006
309 MITRAL VALVE DISEASE 1 0.0006
310 MUSCLE CRAMP 1 0.0006
311 DIVERTICULUM 4 0.0006
312 NASAL OEDEMA 1 0.0006
313 VENOUS OCCLUSION 1 0.0005
314 BLINDNESS TRANSIENT 4 0.0005
315 VITRITIS 1 0.0005
316 NECROSIS 3 0.0005
317 DYSENTERY 1 0.0005
318 RETINOPATHY 2 0.0005
319 WHITE BLOOD CELLS URINE POSITIVE 1 0.0005
320 HYPOPROTEINAEMIA 1 0.0005
321 SCAR 9 0.0005
322 HYPERCOAGULATION 1 0.0005
323 EYE INFLAMMATION 5 0.0005
324 HYPOREFLEXIA 1 0.0005
325 OCULAR HYPERTENSION 1 0.0005
326 CUTANEOUS LUPUS ERYTHEMATOSUS 1 0.0005
327 HYPERAEMIA 1 0.0005
328 CATARACT OPERATION 3 0.0005
329 ENDOPHTHALMITIS 3 0.0005
330 INJECTION SITE VESICLES 3 0.0005
331 MUSCLE CONTRACTURE 1 0.0005
332 POLYCYTHAEMIA 1 0.0005
333 MICROCYTIC ANAEMIA 1 0.0005
334 ACCIDENTAL EXPOSURE 2 0.0005
335 VASCULAR OCCLUSION 1 0.0005
336 PHARYNGEAL ERYTHEMA 1 0.0005
337 POST PROCEDURAL COMPLICATION 9 0.0005
338 PURULENT DISCHARGE 2 0.0005
339 FACIAL PALSY 1 0.0005
340 REFUSAL OF TREATMENT BY PATIENT 3 0.0005
341 POLYP 3 0.0005
342 CORNEAL DISORDER 1 0.0005
343 CATARACT 27 0.0005
344 RENAL COLIC 1 0.0004
345 PERIARTHRITIS 1 0.0004
346 CONTRAST MEDIA REACTION 1 0.0004
347 TRANSPLANT 1 0.0004
348 PULSE ABSENT 2 0.0004
349 DISEASE RECURRENCE 20 0.0004
350 LACUNAR INFARCTION 1 0.0004
351 PREMATURE RUPTURE OF MEMBRANES 1 0.0004
352 ORAL INTAKE REDUCED 1 0.0004
353 VITREOUS FLOATERS 4 0.0004
354 EXPIRED DRUG ADMINISTERED 2 0.0004
355 VENTRICULAR HYPERTROPHY 1 0.0004
356 CORONARY ARTERY STENOSIS 2 0.0004
357 LABYRINTHITIS 1 0.0004
358 CEREBRAL ISCHAEMIA 2 0.0004
359 PHYSICAL DECONDITIONING 1 0.0004
360 EXFOLIATIVE RASH 1 0.0004
361 PHARYNGOLARYNGEAL PAIN 2 0.0004
362 ANIMAL BITE 1 0.0004
363 LARYNGOSPASM 1 0.0004
364 GASTROINTESTINAL INJURY 1 0.0004
365 TYPE IV HYPERSENSITIVITY REACTION 1 0.0004
366 PHOTOSENSITIVITY REACTION 6 0.0004
367 SKIN HYPERTROPHY 1 0.0004
368 CEREBRAL THROMBOSIS 1 0.0004
369 SCAB 4 0.0004
370 TUMOUR HAEMORRHAGE 1 0.0004
371 HISTIOCYTOSIS HAEMATOPHAGIC 1 0.0003
372 EYE DISORDER 11 0.0003
373 URINE ANALYSIS ABNORMAL 1 0.0003
374 IRITIS 1 0.0003
375 PROSTATITIS 1 0.0003
376 LARYNGEAL OEDEMA 2 0.0003
377 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
378 INFUSION SITE SWELLING 2 0.0003
379 NON-CARDIAC CHEST PAIN 1 0.0003
380 GLAUCOMA 6 0.0003
381 DRUG RESISTANCE 8 0.0003
382 VENTRICULAR HYPOKINESIA 1 0.0003
383 NEPHRITIS 1 0.0003
384 TOXIC SKIN ERUPTION 3 0.0003
385 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
386 PALLOR 8 0.0003
387 PUSTULAR PSORIASIS 1 0.0003
388 DIFFICULTY IN WALKING 1 0.0003
389 HYPERREFLEXIA 1 0.0003
390 INCONTINENCE 3 0.0003
391 NEONATAL RESPIRATORY DISTRESS SYNDROME 1 0.0003
392 THERMAL BURN 2 0.0003
393 BRONCHOSPASM 4 0.0003
394 DERMATITIS BULLOUS 2 0.0003
395 DRUG EFFECT INCOMPLETE 10 0.0003
396 THROMBOCYTOSIS 1 0.0003
397 ALCOHOL USE 1 0.0003
398 TRANSIENT ISCHAEMIC ATTACK 9 0.0003
399 THERAPEUTIC RESPONSE DECREASED 16 0.0003
400 MYOCARDIAL ISCHAEMIA 3 0.0003
401 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 1 0.0003
402 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
403 COMMUNICATION DISORDER 1 0.0003
404 ATRIOVENTRICULAR BLOCK 2 0.0003
405 CAESAREAN SECTION 3 0.0003
406 SPINAL CORD COMPRESSION 1 0.0003
407 INFUSION RELATED REACTION 17 0.0003
408 RESPIRATORY ACIDOSIS 1 0.0003
409 NAIL DISCOLOURATION 1 0.0003
410 SUSPECTED COUNTERFEIT PRODUCT 1 0.0003
411 CEREBRAL ATROPHY 1 0.0003
412 ATRIAL FLUTTER 2 0.0003
413 BLEPHARITIS 1 0.0002
414 LEG AMPUTATION 1 0.0002
415 GASTROINTESTINAL PERFORATION 1 0.0002
416 INJECTION SITE DISCOLOURATION 3 0.0002
417 LIP OEDEMA 1 0.0002
418 BUNDLE BRANCH BLOCK LEFT 1 0.0002
419 INJECTION SITE IRRITATION 3 0.0002
420 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
421 AORTIC VALVE INCOMPETENCE 1 0.0002
422 INFUSION SITE PAIN 3 0.0002
423 PRODUCT COMMUNICATION ISSUE 2 0.0002
424 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
425 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
426 ABDOMINAL HERNIA 1 0.0002
427 LUMBAR VERTEBRAL FRACTURE 1 0.0002
428 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
429 ISCHAEMIA 1 0.0002
430 EYE OPERATION 1 0.0002
431 MULTIPLE MYELOMA 1 0.0002
432 LEUKAEMIA 2 0.0002
433 PARALYSIS 3 0.0002
434 GUILLAIN-BARRE SYNDROME 1 0.0002
435 RENAL CELL CARCINOMA 1 0.0002
436 CARDIOMYOPATHY 3 0.0002
437 DYSPHORIA 1 0.0002
438 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 14 0.0002
439 SUBARACHNOID HAEMORRHAGE 2 0.0002
440 PHLEBITIS 1 0.0002
441 PERIPHERAL VASCULAR DISORDER 1 0.0002
442 PERITONITIS 4 0.0002
443 PRODUCT USE IN UNAPPROVED INDICATION 46 0.0002
444 FAECALOMA 1 0.0002
445 CHOKING SENSATION 1 0.0002
446 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
447 STREPTOCOCCAL INFECTION 1 0.0002
448 ANGIOPATHY 1 0.0002
449 INTESTINAL PERFORATION 2 0.0002
450 ACUTE PULMONARY OEDEMA 1 0.0002
451 FACE OEDEMA 3 0.0002
452 PERIORBITAL SWELLING 1 0.0002
453 CHOLECYSTITIS ACUTE 1 0.0002
454 BACK PAIN 41 0.0002
455 IMPAIRED DRIVING ABILITY 2 0.0002
456 NEUTROPHILIA 1 0.0002
457 BLOOD URIC ACID INCREASED 1 0.0002
458 HYPERVENTILATION 1 0.0002
459 EYELID OEDEMA 2 0.0002
460 COLD SWEAT 3 0.0002
461 CONDITION AGGRAVATED 51 0.0002
462 HEARING IMPAIRED 1 0.0002
463 HEPATITIS CHOLESTATIC 1 0.0002
464 CORONARY ARTERY DISEASE 5 0.0002
465 CARDIOMEGALY 2 0.0002
466 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
467 OFF LABEL USE 140 0.0002
468 MUSCLE ATROPHY 2 0.0002
469 THERAPY NON-RESPONDER 7 0.0002
470 ANOREXIA 2 0.0002
471 HERPES SIMPLEX 1 0.0002
472 VISION BLURRED 21 0.0002
473 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
474 JOINT RANGE OF MOTION DECREASED 2 0.0001
475 UVEITIS 2 0.0001
476 PRODUCT LABEL ISSUE 1 0.0001
477 BODY TEMPERATURE INCREASED 3 0.0001
478 NEPHROTIC SYNDROME 1 0.0001
479 CORONARY ARTERY OCCLUSION 2 0.0001
480 AUTOIMMUNE HEPATITIS 1 0.0001
481 APPLICATION SITE REACTION 1 0.0001
482 EYE PAIN 8 0.0001
483 METASTASIS 1 0.0001
484 ANGINA PECTORIS 4 0.0001
485 RASH PUSTULAR 1 0.0001
486 HYPOPHOSPHATAEMIA 1 0.0001
487 KETOACIDOSIS 1 0.0001
488 PAROSMIA 1 0.0001
489 PEMPHIGOID 1 0.0001
490 TROPONIN INCREASED 1 0.0001
491 SKIN DISCOLOURATION 6 0.0001
492 MATERNAL DRUGS AFFECTING FOETUS 1 0.0001
493 VISUAL IMPAIRMENT 16 0.0001
494 HYPOALBUMINAEMIA 1 0.0001
495 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
496 ARRHYTHMIA 6 0.0001
497 MYASTHENIA GRAVIS 1 0.0001
498 PRESYNCOPE 3 0.0001
499 ASPHYXIA 1 0.0001
500 HYPERAESTHESIA 1 0.0001
501 LUNG NEOPLASM MALIGNANT 5 0.0001
502 MYOCARDIAL INFARCTION 21 0.0001
503 CARDIO-RESPIRATORY ARREST 5 0.0001
504 BLOOD UREA INCREASED 2 0.0001
505 DRUG EXPOSURE DURING PREGNANCY 4 0.0001
506 LOSS OF CONSCIOUSNESS 15 0.0001
507 ANAPHYLACTIC SHOCK 3 0.0001
508 HAEMATOMA 3 0.0001
509 DEAFNESS 3 0.0001
510 GROIN PAIN 1 0.0001
511 LUNG INFILTRATION 1 0.0001
512 BLOOD PRESSURE INCREASED 17 0.0001
513 SYNCOPE 11 0.0001
514 PNEUMONIA BACTERIAL 1 0.0001
515 RESPIRATORY DISTRESS 3 0.0001
516 IRON DEFICIENCY ANAEMIA 1 0.0001
517 WOUND 3 0.0001
518 MIDDLE INSOMNIA 2 0.0001
519 HEPATIC CIRRHOSIS 2 0.0001
520 PHOTOPHOBIA 2 0.0001
521 HAEMORRHAGE 11 0.0001
522 ATELECTASIS 1 0.0001
523 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
524 URINARY INCONTINENCE 3 0.0001
525 PRODUCT USE ISSUE 19 0.0001
526 EYELID PTOSIS 1 0.0001
527 MOTOR DYSFUNCTION 1 0.0001
528 DRUG ADMINISTRATION ERROR 3 0.0001
529 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
530 DERMATITIS 2 0.0001
531 MUSCULOSKELETAL PAIN 5 0.0001
532 HALLUCINATION, VISUAL 2 0.0001
533 JOINT DISLOCATION 1 0.0001
534 MELAENA 2 0.0001
535 APPLICATION SITE PAIN 2 0.0001
536 ANAPHYLACTIC REACTION 5 0.0001
537 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
538 NERVE INJURY 1 0.0001
539 SNEEZING 2 0.0001
540 PANCREATITIS ACUTE 2 0.0001
541 CHROMATURIA 2 0.0001
542 MICTURITION URGENCY 1 0.0001
543 CARDIAC FAILURE CONGESTIVE 7 0.0001
544 NEOPLASM 1 0.0001
545 SHOCK 2 0.0001
546 HEART RATE DECREASED 3 0.0001
547 COMA 4 0.0001
548 CHOLECYSTITIS 1 0.0001
549 MYOCLONUS 1 0.0001
550 ACCIDENT 1 0.0001
551 BLOOD PRESSURE FLUCTUATION 2 0.0001
552 C-REACTIVE PROTEIN INCREASED 3 0.0001
553 NOCTURIA 1 0.0001
554 NO THERAPEUTIC RESPONSE 1 0.0001
555 GENERALISED OEDEMA 1 0.0001
556 ILEUS 1 0.0001
557 SECRETION DISCHARGE 1 0.0001
558 RASH GENERALISED 2 0.0001
559 INJECTION SITE INDURATION 1 0.0001
560 BLOOD CREATININE INCREASED 5 0.0001
561 JOINT STIFFNESS 2 0.0001
562 ANKYLOSING SPONDYLITIS 1 0.0001
563 PULMONARY CONGESTION 1 0.0001
564 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
565 BLOOD PRESSURE DECREASED 5 0.0001
566 EAR INFECTION 2 0.0001
567 MALIGNANT MELANOMA 1 0.0001
568 TACHYPNOEA 1 0.0001
569 PERIPHERAL COLDNESS 1 0.0001
570 INJECTION SITE REACTION 5 0.0001
571 HYPOMAGNESAEMIA 1 0.0001
572 NECK PAIN 4 0.0001
573 MASS 1 0.0001
574 BLISTER 4 0.0001
575 SKIN REACTION 1 0.0001
576 SEASONAL ALLERGY 1 0.0001
577 CHEST PAIN 13 0.0001
578 CONVULSION 4 0.0001
579 HYPERHIDROSIS 9 0.0001
580 SUBDURAL HAEMATOMA 1 0.0001
581 HYPOACUSIS 3 0.0001
582 PARAESTHESIA ORAL 1 0.0001
583 ANOSMIA 1 0.0001
584 HYPOKINESIA 1 0.0001
585 INTENTIONAL PRODUCT USE ISSUE 6 0.0001
586 ACUTE MYOCARDIAL INFARCTION 2 0.0001
587 PULMONARY MASS 1 0.0001
588 THROAT IRRITATION 3 0.0001
589 LACRIMATION INCREASED 2 0.0001
590 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
591 THYROID DISORDER 1 0.0001
592 MUSCULOSKELETAL CHEST PAIN 1 0.0001
593 OCULAR HYPERAEMIA 3 0.0001
594 HEAD INJURY 2 0.0001
595 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
596 PNEUMOTHORAX 1 0.0001
597 CYSTITIS 2 0.0001
598 SENSORY DISTURBANCE 1 0.0001
599 ATRIAL FIBRILLATION 6 0.0001
600 VENTRICULAR TACHYCARDIA 1 0.0001
601 HYPOAESTHESIA 9 0.0001
602 VIRAL INFECTION 2 0.0001
603 LEUKOPENIA 3 0.0001
604 PERICARDITIS 1 0.0001
605 SKIN EXFOLIATION 5 0.0001
606 CIRCULATORY COLLAPSE 1 0.0001
607 HAEMATURIA 2 0.0001
608 MULTI-ORGAN FAILURE 1 0.0001
609 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
610 OEDEMA PERIPHERAL 7 0.0001
611 LOCAL SWELLING 1 0.0001
612 HYPOXIA 2 0.0001
613 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
614 DRUG ERUPTION 1 0.0001
615 GALLBLADDER DISORDER 1 0.0001
616 DRUG EFFECT DECREASED 3 0.0001
617 INJECTION SITE PAIN 17 0.0001
618 OEDEMA 3 0.0001
619 LEUKOCYTOSIS 1 0.0001
620 RESPIRATORY FAILURE 4 0.0001
621 MEDICATION ERROR 3 0.0001
622 CONJUNCTIVITIS 1 0.0001
623 HEPATIC STEATOSIS 1 0.0001
624 HEPATIC FUNCTION ABNORMAL 2 0.0001
625 CEREBROVASCULAR ACCIDENT 9 0.0001
626 INTESTINAL OBSTRUCTION 2 0.0001
627 BLOOD SODIUM DECREASED 1 0.0001
628 FRACTURE 1 0.0001
629 PULMONARY FIBROSIS 1 0.0001
630 CHOLESTASIS 1 0.0001
631 BONE PAIN 3 0.0001
632 SKIN FISSURES 1 0.0001
633 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
634 ABNORMAL BEHAVIOUR 2 0.0001
635 DISORIENTATION 2 0.0001
636 PREGNANCY 1 0.0000
637 VERTIGO 3 0.0000
638 DISCOMFORT 3 0.0000
639 RIB FRACTURE 1 0.0000
640 HYPERSENSITIVITY 9 0.0000
641 INJECTION SITE ERYTHEMA 6 0.0000
642 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
643 URTICARIA 8 0.0000
644 RETCHING 1 0.0000
645 SKIN CANCER 1 0.0000
646 RHINORRHOEA 3 0.0000
647 PRURITUS GENERALISED 1 0.0000
648 FAECES DISCOLOURED 1 0.0000
649 MENTAL DISORDER 2 0.0000
650 LIVER DISORDER 2 0.0000
651 PULMONARY OEDEMA 2 0.0000
652 RASH PAPULAR 1 0.0000
653 NO ADVERSE EVENT 8 0.0000
654 GENERAL PHYSICAL HEALTH DETERIORATION 5 0.0000
655 MOBILITY DECREASED 3 0.0000
656 BLOOD GLUCOSE DECREASED 2 0.0000
657 HYPOGLYCAEMIA 2 0.0000
658 NEURALGIA 1 0.0000
659 PAIN IN EXTREMITY 12 0.0000
660 EPISTAXIS 3 0.0000
661 PNEUMONIA ASPIRATION 1 0.0000
662 HYPOTENSION 8 0.0000
663 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
664 FLUID RETENTION 2 0.0000
665 CHEST DISCOMFORT 4 0.0000
666 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
667 ERYTHEMA 8 0.0000
668 INFLAMMATION 2 0.0000
669 UNRESPONSIVE TO STIMULI 1 0.0000
670 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
671 DIPLOPIA 1 0.0000
672 ECZEMA 2 0.0000
673 SPEECH DISORDER 2 0.0000
674 ANHEDONIA 1 0.0000
675 BRADYCARDIA 2 0.0000
676 FEAR 1 0.0000
677 JAUNDICE 1 0.0000
678 BLOOD BILIRUBIN INCREASED 1 0.0000
679 THROAT TIGHTNESS 1 0.0000
680 RASH PRURITIC 2 0.0000
681 TREATMENT NONCOMPLIANCE 2 0.0000
682 SKIN LESION 1 0.0000
683 DIZZINESS 18 0.0000
684 FEELING COLD 1 0.0000
685 DEMENTIA 1 0.0000
686 HYPONATRAEMIA 2 0.0000
687 ASTHMA 4 0.0000
688 MYALGIA 6 0.0000
689 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
690 MUSCULOSKELETAL STIFFNESS 3 0.0000
691 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
692 BLADDER CANCER 2 0.0000
693 ARTHRALGIA 14 0.0000
694 RESPIRATORY DISORDER 1 0.0000
695 PREMATURE BABY 1 0.0000
696 HYPERTENSION 7 0.0000
697 EPILEPSY 1 0.0000
698 MUSCLE SPASMS 6 0.0000
699 FEELING HOT 2 0.0000
700 GYNAECOMASTIA 1 0.0000
701 PULMONARY EMBOLISM 3 0.0000
702 HIP FRACTURE 1 0.0000
703 AMNESIA 2 0.0000
704 CHOLELITHIASIS 1 0.0000
705 DYSPEPSIA 3 0.0000
706 HEART RATE INCREASED 3 0.0000
707 LIP SWELLING 1 0.0000
708 URINARY RETENTION 1 0.0000
709 HEPATIC ENZYME INCREASED 2 0.0000
710 SINUSITIS 3 0.0000
711 ASTHENIA 11 0.0000
712 GASTRIC DISORDER 1 0.0000
713 NIGHTMARE 1 0.0000
714 NEOPLASM PROGRESSION 1 0.0000
715 HEADACHE 18 0.0000
716 RASH MACULAR 1 0.0000
717 INJURY 2 0.0000
718 PNEUMONIA 9 0.0000
719 HYPERGLYCAEMIA 1 0.0000
720 UNDERDOSE 2 0.0000
721 RESTLESSNESS 1 0.0000
722 DYSURIA 1 0.0000
723 DYSGEUSIA 2 0.0000
724 EYE SWELLING 1 0.0000
725 HOT FLUSH 2 0.0000
726 UNEVALUABLE EVENT 2 0.0000
727 MUSCULAR WEAKNESS 3 0.0000
728 INJECTION SITE SWELLING 2 0.0000
729 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
730 NAUSEA 20 0.0000
731 INJECTION SITE BRUISING 2 0.0000
732 ABORTION SPONTANEOUS 1 0.0000
733 CONFUSIONAL STATE 4 0.0000
734 DYSPNOEA 14 0.0000
735 DYSKINESIA 1 0.0000
736 ANXIETY 7 0.0000
737 NEUTROPHIL COUNT DECREASED 1 0.0000
738 INFLUENZA LIKE ILLNESS 2 0.0000
739 ABDOMINAL PAIN UPPER 5 0.0000
740 CARDIAC ARREST 2 0.0000
741 FALL 8 0.0000
742 COMPLETED SUICIDE 2 0.0000
743 RHABDOMYOLYSIS 1 0.0000
744 RENAL IMPAIRMENT 2 0.0000
745 BALANCE DISORDER 2 0.0000
746 VAGINAL HAEMORRHAGE 1 0.0000
747 SEPTIC SHOCK 1 0.0000
748 TACHYCARDIA 2 0.0000
749 DEHYDRATION 3 0.0000
750 PRODUCT QUALITY ISSUE 3 0.0000
751 NEPHROLITHIASIS 1 0.0000
752 TINNITUS 1 0.0000
753 HYPOKALAEMIA 1 0.0000
754 COUGH 6 0.0000
755 SWELLING 2 0.0000
756 RASH ERYTHEMATOUS 1 0.0000
757 DEATH 18 0.0000
758 DRUG INTOLERANCE 2 0.0000
759 DRY EYE 1 0.0000
760 SOMNOLENCE 4 0.0000
761 CELLULITIS 1 0.0000
762 DRUG INEFFECTIVE 26 0.0000
763 FLUSHING 2 0.0000
764 VOMITING 9 0.0000
765 NERVOUSNESS 1 0.0000
766 INSOMNIA 5 0.0000
767 DRUG DOSE OMISSION 3 0.0000
768 PANCYTOPENIA 1 0.0000
769 THROMBOCYTOPENIA 2 0.0000
770 FLATULENCE 1 0.0000
771 EYE IRRITATION 1 0.0000
772 ABDOMINAL PAIN 4 0.0000
773 DYSPHONIA 1 0.0000
774 PALPITATIONS 2 0.0000
775 CHILLS 2 0.0000
776 WHEEZING 1 0.0000
777 SUICIDE ATTEMPT 1 0.0000
778 PLEURAL EFFUSION 1 0.0000
779 PAIN 10 0.0000
780 ANAEMIA 3 0.0000
781 SWELLING FACE 1 0.0000
782 RENAL FAILURE 2 0.0000
783 DRY SKIN 2 0.0000
784 NEOPLASM MALIGNANT 1 0.0000
785 INJECTION SITE PRURITUS 1 0.0000
786 SLEEP DISORDER 1 0.0000
787 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
788 SKIN BURNING SENSATION 1 0.0000
789 INFECTION 2 0.0000
790 HALLUCINATION 1 0.0000
791 DEPRESSION 3 0.0000
792 INCORRECT DOSE ADMINISTERED 3 0.0000
793 HOSPITALISATION 2 0.0000
794 FATIGUE 10 0.0000
795 ARTHRITIS 1 0.0000
796 DRUG INTERACTION 2 0.0000
797 CARDIAC FAILURE 1 0.0000
798 THROMBOSIS 1 0.0000
799 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
800 TREATMENT FAILURE 1 0.0000
801 RASH 5 0.0000
802 MALAISE 5 0.0000
803 CARDIAC DISORDER 1 0.0000
804 BLOOD GLUCOSE INCREASED 2 0.0000
805 GAIT DISTURBANCE 2 0.0000
806 PRURITUS 4 0.0000
807 CONTUSION 1 0.0000
808 ABDOMINAL DISTENSION 1 0.0000
809 PLATELET COUNT DECREASED 1 0.0000
810 DIARRHOEA 6 0.0000
811 OVERDOSE 2 0.0000
812 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
813 INFLUENZA 1 0.0000
814 SEPSIS 1 0.0000
815 SEIZURE 1 0.0000
816 DECREASED APPETITE 2 0.0000
817 JOINT SWELLING 1 0.0000
818 EMOTIONAL DISTRESS 1 0.0000
819 PSORIASIS 1 0.0000
820 WEIGHT DECREASED 2 0.0000
821 PERIPHERAL SWELLING 1 0.0000
822 PARAESTHESIA 1 0.0000
823 ABDOMINAL DISCOMFORT 1 0.0000
824 URINARY TRACT INFECTION 1 0.0000
825 PYREXIA 2 0.0000
826 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
827 NASOPHARYNGITIS 1 0.0000
828 ALOPECIA 1 0.0000
829 CONSTIPATION 1 0.0000
830 WEIGHT INCREASED 1 0.0000
831 FEELING ABNORMAL 1 0.0000